Drugs / dendritic and cytokine-induced killer cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01839539 | Mar 2013 → Mar 2018 | colorectal cancer | Guangxi Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dendritic and cytokine-induced killer cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01839539 ↗ |
| Known as | DC-CIK | “receive 2-3 cycles of Dendritic and Cytokine-induced Killer Cells (DC-CIK) treatment” NCT01839539 ↗ |
| Modality | Cell therapy | “receive 2-3 cycles of Dendritic and Cytokine-induced Killer Cells (DC-CIK) treatment” NCT01839539 ↗ |